Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, reflecting a new version of the ClinicalTrials.gov content without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-31T16:39:27.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, indicating a newer page build. No study content or user-facing functionality changes are indicated.
    Difference
    0.1%
    Check dated 2026-08-17T12:56:30.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The release notes section now shows Revision: v3.6.4, replacing the previous v3.6.3 entry.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:26.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor revision to the page's documentation/metadata.
    Difference
    0.1%
    Check dated 2026-07-05T04:57:59.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 is now shown in the page footer. This indicates a newer version of the page content.
    Difference
    0.1%
    Check dated 2026-06-28T01:33:48.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no ongoing participant enrollment. The page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, along with a revision note to v3.6.0 (replacing v3.5.5).
    Difference
    0.6%
    Check dated 2026-06-13T17:38:50.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.